Sectors

WHWK
Whitehawk Therapeutics Inc
3.92
2 x 3.91
1 x 3.93
bid
ask
+
0.01
0.26%
10:06 AM
timesize
Ytd61.98%
1y109.63%
3.87
day range
3.96
1.57
52 week range
5.50
Open3.90Prev Close3.91Low3.87High3.96Mkt Cap193.36M
Vol18.64KAvg Vol462.71KEPS-1.68P/E-2.33Forward P/EN/A
Beta0.77Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg4.23200-d Avg3.251yr Est0.00
Income Statement
Operating Expenses23.52M
Research and Development Expense17.23M
Selling, General and Administrative Expense6.29M
Operating Income-23.52M
Net Income-22.19M
Net Income Common Stock-22.19M
Net Income Common Stock (USD)-22.19M
Consolidated Income-22.19M
Earnings per Basic Share-0.32
Earnings per Basic Share (USD)-0.32
Earnings per Diluted Share-0.32
Earning Before Interest & Taxes (EBIT)-22.19M
Earning Before Interest & Taxes (USD)-22.19M
Weighted Average Shares69.24M
Weighted Average Shares Diluted69.24M
Balance Sheet
Cash and Equivalents34.79M
Cash and Equivalents (USD)34.79M
Investments88.25M
Investments Current88.25M
Current Assets125.55M
Property, Plant & Equipment Net2.00K
Total Assets127.23M
Current Liabilities11.06M
Total Liabilities11.06M
Accumulated Retained Earnings (Deficit)-375.44M
Accumulated Other Comprehensive Income-15.00K
Shareholders Equity116.18M
Shareholders Equity (USD)116.18M
Assets Non-Current1.68M
Trade and Non-Trade Payables1.75M
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow / Change in Cash & Cash Equivalents-2.78M
Net Cash Flow from Investing19.43M
Net Cash Flow - Investment Acquisitions and Disposals19.43M
Net Cash Flow from Operations-22.21M
Share Based Compensation2.19M